Immunotherapy

The new advanced microscopy platform can identify the immune checkpoints that buffer the anti-tumor response

Neutrophil granulocytes can be trained to attack tumors using beta-glucan, a sugar found in fungi, oats, and barley

The analysis highlights the diversity of immune responses in pancreatic cancer and the need for personalized treatments

Researchers gain new insight into why patients who initially respond well to immunotherapy drugs known as checkpoint inhibitors can develop resistance to these therapies

Researchers from Penn, in collaboration with the Ragon Institute, develop a new dual CAR T cell immunotherapy that combats HIV infection in humanized mice

The vaccine primes the immune system to launch an effective T-cell attack

New diagnostic test for MSI in solid tumors can inform physicians on immuno-oncology therapies, and can guide treatment decisions for patients with Lynch-associated cancers

Dana-Farber Cancer Institute scientists have identified several features of kidney cancer tumors that influence their response to immune checkpoint inhibitor drugs

Previous studies have shown that not all patients with metastatic breast cancer benefit from immunotherapy

The largest report of commercial CAR T therapy for lymphoma demonstrates its effectiveness even in patients that would not have been eligible for clinical trials